CD8A and neoplasm: However, the administration of mifepristone, a glucocorticoid receptor inhibitor, did not suppress CXCR4 expression in tumor‐infiltrated CD8+ T cells, suggesting that glucocorticoid signaling has a minimal effect on CXCR4 regulation in these cells (Figure S4).